Bristol-Myers Squibb Co (STU:BRM) Forward Dividend Yield %: 4.37% (As of Jul. 02, 2026)


STU:BRM Bristol-Myers Squibb Co STU:BRM
78 GF Score
Price €49.62
GF Value €48.49
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Bristol-Myers Squibb Co Forward Dividend Yield %?

Bristol-Myers Squibb Co STU:BRM -1.83% 78 Forward Dividend Yield % is 4.37% as of Jul. 02, 2026. GuruFocus rates STU:BRM with a GF Score™ of 78/100 and a GF Value™ of €48.49 (Fairly Valued). The stock has 5 warning signs investors should review. Among 506 Drug Manufacturers companies, Bristol-Myers Squibb Co ranks better than 83% on this metric.

As of today (2026-07-02), the Forward Annual Dividend Yield of Bristol-Myers Squibb Co is 4.37%.

As of today (2026-07-02), the Trailing Annual Dividend Yield of Bristol-Myers Squibb Co is 4.34%.

STU:BRM's Forward Dividend Yield % is ranked better than
83% of 506 companies
in the Drug Manufacturers industry
Industry Median: 2.085 vs STU:BRM: 4.37

Bristol-Myers Squibb Co's Dividends per Share for the three months ended in Mar. 2026 was €0.55.

During the past 12 months, Bristol-Myers Squibb Co's average Dividends Per Share Growth Rate was 2.50% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 4.40% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 6.30% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 6.00% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Bristol-Myers Squibb Co was 14.20% per year. The lowest was 0.00% per year. And the median was 3.50% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Bristol-Myers Squibb Co  (STU:BRM) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

Bristol-Myers Squibb Co Forward Dividend Yield % Related Terms

STU:BRM vs PFE, GILD, AMGN: Forward Dividend Yield % Comparison

For the Drug Manufacturers - General subindustry, Bristol-Myers Squibb Co's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bristol-Myers Squibb Co Forward Dividend Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bristol-Myers Squibb Co's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Bristol-Myers Squibb Co's Forward Dividend Yield % falls into.


STU:BRM
78GF Score
Bristol-Myers Squibb Co STU:BRM
Forward Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bristol-Myers Squibb Co Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Bristol-Myers Squibb Co Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
USD 0.6300002026-07-022026-07-022026-08-03Cash DividendquarterlyUSD:EUR 0.856000
USD 0.6300002026-04-022026-04-022026-05-01Cash DividendquarterlyUSD:EUR 0.855000
USD 0.6300002026-01-022026-01-022026-02-02Cash DividendquarterlyUSD:EUR 0.851000
USD 0.6200002025-10-032025-10-032025-11-03Cash DividendquarterlyUSD:EUR 0.859000
USD 0.6200002025-07-032025-07-032025-08-01Cash DividendquarterlyUSD:EUR 0.857000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

Bristol-Myers Squibb Co's Forward Annual Dividend Yield (%) for Today is calculated as

Forward Annual Dividend Yield=Forward Full Year Dividend/Current Share Price
=2.15712/49.615
=4.35 %

Current Share Price is €49.615.
Bristol-Myers Squibb Co's Dividends per Share for the forward twelve months is calculated as €0.53928 * 4 = €2.15712.

Bristol-Myers Squibb Co's Trailing Annual Dividend Yield (%) for Today is calculated as

Trailing Annual Dividend Yield=Most Recent Full Year Dividend/Current Share Price
=2.67798/49.615
=5.40 %

Current Share Price is €49.615.
Bristol-Myers Squibb Co's Dividends per Share for the trailing twelve months (TTM) ended in Today is €2.67798.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Forward Dividend Yield % of 4.37% mean?
Bristol-Myers Squibb Co (STU:BRM) has a Forward Dividend Yield % of 4.37% as of Jul. 02, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Bristol-Myers Squibb Co and its competitors. According to the industry distribution chart, Bristol-Myers Squibb Co ranks #86 out of 506 companies in the Drug Manufacturers industry, placing it in the top 17%.
Is Bristol-Myers Squibb Co's Forward Dividend Yield % too high?
Bristol-Myers Squibb Co's current Forward Dividend Yield % is 4.37%. The Drug Manufacturers industry median Forward Dividend Yield % is 2.09. Bristol-Myers Squibb Co's value of 4.37% is 109.6% above this industry median. Based on the distribution chart, Bristol-Myers Squibb Co ranks #86 out of 506 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Bristol-Myers Squibb Co has a GF Score™ of 78/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Bristol-Myers Squibb Co's Forward Dividend Yield % compare to PFE and GILD?
According to the Drug Manufacturers industry distribution chart, Bristol-Myers Squibb Co ranks #86 out of 506 companies for Forward Dividend Yield %. This places Bristol-Myers Squibb Co in the top 17% of its industry — outperforming the majority of peers. The industry median Forward Dividend Yield % is 2.09. Bristol-Myers Squibb Co's value of 4.37% is 109.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Drug Manufacturers company?
The median Forward Dividend Yield % among Drug Manufacturers companies is 2.09, based on 506 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bristol-Myers Squibb Co's current Forward Dividend Yield % of 4.37% is 109.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Bristol-Myers Squibb Co and its competitors. For the Drug Manufacturers industry, the median Forward Dividend Yield % is 2.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bristol-Myers Squibb Co's current Forward Dividend Yield % is 4.37%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bristol-Myers Squibb Co stock overvalued right now?
Based on GuruFocus' analysis, Bristol-Myers Squibb Co (STU:BRM) is currently considered Fairly Valued. The stock's GF Value™ is €48.49, compared to a current price of €49.62 — trading 2.3% above its estimated fair value. The current Forward Dividend Yield % is 4.37% and 109.6% above the Drug Manufacturers industry median of 2.09. Bristol-Myers Squibb Co's overall GF Score™ is 78/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Bristol-Myers Squibb Co (STU:BRM), the current Forward Dividend Yield % is 4.37% as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bristol-Myers Squibb Co (STU:BRM) Overvalued in 2026?

Based on GuruFocus' analysis, Bristol-Myers Squibb Co stock appears to be overvalued. The current stock price of €49.62 is trading 2.3% above its estimated GF Value™ of €48.49. GuruFocus considers Bristol-Myers Squibb Co to be Fairly Valued.

Key valuation signals for STU:BRM:

  • Forward Dividend Yield %: 4.37%
  • GF Value™: €48.49 vs. price of €49.62 (2.3% above fair value)
  • GF Score™: 78/100 with 5 warning signs
  • Industry Position: 109.6% above the Drug Manufacturers median (#86 of 506)

No single metric tells the full story. See the STU:BRM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bristol-Myers Squibb Co Business Description

Address Route 206 and Province Line Road, Princeton, New Jersey, NJ, USA, 08543
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
78GF Score

Get the complete analysis for STU:BRM

Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€49.62
Price
€48.49
GF Value